Changes in platelet GPIbα and ADAM17 during the acute stage of atherosclerotic ischemic stroke among Chinese

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 33, Issue 3, 2013, Pages 438-442

  Ling, Jia Yan ^a,b   Shen, Lin ^a   Liu, Qing ^c   Xue, Sha ^b   Ma, Wei ^b   Wu, Hui ^b   Li, Zi Xi ^b   Zhu, Rui ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b First Hospital of Wuhan   (China)

^c Medicine Hospital of Hubei Province   (China)

Author keywords

ADAM17; glycocalicin; GPIb ; platelets; stroke

Indexed keywords

ADAM PROTEIN; ADHESION RECEPTOR; BIOLOGICAL MARKER; THROMBIN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; TUMOR NECROSIS FACTOR-ALPHA CONVERTASE;

ARTICLE; BLOOD; BRAIN ATHEROSCLEROSIS; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHINA; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; THROMBOCYTE;

ADAM PROTEINS; BIOLOGICAL MARKERS; BLOOD PLATELETS; BRAIN ISCHEMIA; CHINA; FEMALE; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; MALE; MIDDLE AGED; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STROKE;

EID: 84879290769     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-013-1138-3     Document Type: Article

References (23)

1. Lopez AD, Mathers CD, Ezzati M, et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet, 2006, 367(9524):1747-1757
2. Feigin VL, Lawes CM, Bennet DA, et al. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol, 2003,2(1):43-53
3. Stoll G, Kleinschnitz C, Nieswandt B. The role of glycoprotein Ibalpha and von Willebrand factor interaction in stroke development. Hamostaseologie, 2010,30(3): 136-138
4. Bergmeier W, Piffath CL, Cheng G, et al. Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates GPIbalpha shedding from platelets in vitro and in vivo. Circ Res, 2004,95(7):677-683
5. White MM, Jennings LK. Platelet protocols. Research and Clinical Laboratory Procedures. San Diego: Academic Press, 1999
6. Zhang Y, Zhao Y, Lu S, et al. A high-throughput biotinavidin-elisa for studying expression of platelet membrane glycoproteins and its clinical application. Tohoku J Exp Med, 2010,222(1):83-88
7. del Zoppo GJ. The role of platelets in ischemic stroke. Neurology, 1998,51(3 Suppl 3):S9-S14
8. Tokuue J, Hayashi J, Hata Y, et al. Enhanced platelet aggregability under high shear stress after treadmill exercise in patients with effort angina. Thromb Haemost, 1996,75(5):833-837
9. Sonoda A, Murata M, Ito D, et al. Association between platelet glycoprotein Ib genotype and ischemic cerebrovascular disease. Stroke, 2000,31(2):493-497
10. Maguire JM, Thakkinstian A, Sturm J, et al. Polymorphisms in platelet glycoprotein 1balpha and factor VII and risk of ischemic stroke: a meta-analysis. Stroke, 2008,39(6):1710-1716
11. Elvers M, Stegner D, Hagedorn I, et al. Impaired αIIbβ3 integrin activation and shear-dependent thrombus formation in mice lacking phospolipase D1. Sci Signal, 2010, 3(103): ra1
12. Han Y, Wang Z, Zhu M, et al. Study of platelet membrane glycoproteins and its fibrinogen binding reaction in patients with cerebral infarction and diabetes mellitus. Zhonghua Xueyexue Zazhi (Chinese), 2000,21(3):129-131
13. Alan D. Flow cytometry: a clinical test of platelet function. J Blood, 1996, 87(12):4925-4936
14. Dai K, Yan R, Li S, et al. Prolonged inhibition of protein kinase A results in metalloproteinase-dependent platelet GPIba shedding. Thromb Res, 2009,124(1):101-109
15. Brill A, Chauhan AK, Canault M, et al. Oxidative stress activates ADAM17/TACE and induces its target receptor shedding in platelets in a p38-dependent fashion. Cardiovasc Res, 2009,84(1):137-144
16. Aktas B, Pozgajova M, Bergmeier W, et al. Aspirin induces platelet receptor shedding via ADAM17 (TACE). J Biol Chem, 2005,280(48):39716-39722
17. Stoll G, Kleinschnitz C, Nieswandt B. Combating innate inflammation: a new paradigm for acute treatment of stroke? Ann NY Acad Sci, 2010,1207:149-154
18. Boilard E, Nigrovic PA, Larabee K, et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science, 2010,327(5965):580-583
19. Beer JH, Buchi L, Steiner B. Glycocalicin: a new assay-the normal plasma levels and its potential usefulness in selected diseases. Blood, 1994,83(3):691-702
20. Coller BS, Kalomiris E, Steinberg M, et al. Evidence that glycocalicin circulates in normal plasma. J Clin Invest, 1984,73(3):794-799
21. Wang X, Feuerstein GZ, Xu L, et al. Inhibition of tumor necrosis factor-nlpha. converting enzyme by a selective antagonist protects brain from focal ischemic injury in rats. Mol Pharmacol, 2004,65(4):890-896
22. Hurtado O, Lizasoain I, Fernández-Tomé P, et al. TACE/ADAM17-TNFα pathway in rat cortical cultures after exposure to oxygen-glucose deprivation or glutamate. J Cereb Blood Flow Metab, 2002,22(5):576-585
23. Cárdenas A, Moro MA, Leza JC, et al. Up-regulation of TACE/ADAM17 after ischemic preconditioning is involved in brain tolerance. J Cere Blood Flow Metab, 2002,22(11):1297-1302